RECHERCHEDosage des marqueurs tumoraux CYFRA 21-1 et ACEdans le cancer du nasopharynx en Algérie
No Thumbnail Available
Date
2013-03-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
elsevier
Abstract
Nasopharyngeal cancer is one of the most important cancers in our country. It ischaracterized by the influence of different etiologic factors: viral, genetic and environmental.Its diagnosis is delayed by lack of specific tumor markers. The aim of this study was to evaluatethe importance of the use of CYFRA 21-1 and ACE markers in nasopharyngeal carcinoma (NPC).Our prospective study interested 164 patients (132 M, 32 F) with a mean age of 47 years (13 to 70)with 24 of them aged less than 30 years, presenting a nasopharyngeal carcinoma histologicallyconfirmed and 180 healthy controls without evident neoplasm. Undifferentiated forms represent93% of cases. A blood sample was collected from each patient and control before any treatment,as well as controls to measure CYFRA 21-1 and ACE by immunoenzymatic assay. The resultsshowed that the mean serum CYFRA 21-1 values were significantly higher in patients with NPCthan those in controls (P ± 0.001). A significant correlation was found only between the serumCYFRA 21-1 level before treatment and the clinical outcome of patients (P ± 0.0009). Seric levelof CYFRA 21-1 at diagnosis of NPC may play a predictive role to evaluate the risk of metastaticdisease and prognosis.